tiprankstipranks
Trending News
More News >
NeonMind Biosciences Inc (TSE:LCR)
:LCR
Canadian Market

NeonMind Biosciences Inc (LCR) Income Statement

Compare
14 Followers

NeonMind Biosciences Inc Income Statement

Last quarter (Q3 2025), NeonMind Biosciences Inc's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, NeonMind Biosciences Inc's net income was C$-327.37K. See NeonMind Biosciences Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 415.80K
Gross Profit
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 415.55K
Operating Expenses
C$ 1.06M-C$ 1.75MC$ 7.78MC$ 1.06M
Depreciation and Amortization
--C$ 1.13KC$ 689.00C$ 0.00
EBITDA
C$ -897.00-C$ -1.75MC$ -7.83MC$ -1.06M
Operating Income
C$ -1.06M-C$ -1.75MC$ -7.83MC$ -1.06M
Other Income/Expenses
C$ -484.80K-C$ -3.47KC$ 1.13MC$ -971.56K
Pretax Income
C$ -1.55M-C$ -2.03MC$ -6.68MC$ -2.17M
Net Income
C$ -1.54M-C$ -2.03MC$ -7.21MC$ -2.68M
Per Share Metrics
Basic EPS
C$ -0.03C$ -0.08C$ -1.80C$ -7.33C$ -2.86
Diluted EPS
C$ -0.03C$ -0.08C$ -1.80C$ -7.33C$ -2.86
Weighted Average Shares Outstanding
55.69M 45.07M 1.13M 983.30K 936.92K
Weighted Average Shares Outstanding (Diluted)
55.69K 45.07M 1.13M 983.30K 936.92K
Currency in CAD

NeonMind Biosciences Inc Earnings and Revenue History